Stimulated TGF-β/SMAD signaling enhances peritoneal invasion through the secretion of matrix metalloproteinases (MMPs), which degrade the ECM and enable cancer cells to invade surrounding tissues [45]. The gene discussed is TGFB1; the disease is cancer.